1 study found for:    NCT01380600
Show Display Options
Rank Status Study
1 Active, not recruiting Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Condition: Carcinoma, Colorectal
Intervention: Drug: Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)

Indicates status has not been verified in more than two years